A short (3-day) course of azithromycin tablets versus a 10-day course of amoxycillin-clavulanic acid (co-amoxiclav) in the treatment of adults with lower respiratory tract infections and effects on long-term outcome

Authors: Hoepelman I.M.; Mollers M.J.; van Schie M.H.; Greefhorst A.P.M.; Schlosser N.J.J.; Sinninghe Damste E.J.; van de Moosdijk C.N.F.; Dalinghaus W.H.; Eland M.E.; Mol S.J.M.; Rozenberg-Arska M.

Source: International Journal of Antimicrobial Agents, Volume 9, Number 3, January 1998 , pp. 141-146(6)

Publisher: Elsevier

Buy & download fulltext article:

This article is hosted on another website.

You may be required to register, activate a subscription or purchase the article before you can obtain the full text.

Proceed

Keywords: Acute exacerbation of chronic bronchitis; Azithromycin; Co-amoxiclav; Lower respiratory tract infection

Language: English

Document Type: Research article

DOI: http://dx.doi.org/10.1016/S0924-8579(97)00043-5

Affiliations: 1: Department of Medicine, Division of Infectious Diseases and AIDS, University Hospital, PO Box 85.500, 3508 GA Utrecht, The Netherlands

Publication date: 1998-01-01